" class="no-js "lang="en-US"> Johannes de Munter - Medtech Alert
Friday, September 05, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Johannes de Munter

Johannes de Munter

About Johannes de Munter

People management
Strategic management
Clinical Research Development for EU registration
Clinical Research especially ATMP products
Regulatory affairs especially ATMP products (EMA)
Epidemiology

Specialties: Autologous Stem Cell Research and Regulatory
International research development
market development in medical industry
Change management and interim management

Related Story

Clinical Trials

 Dutch Stem Cell Biotech Neuroplast Announces Successful Clinical Phase I Trial with Neuro-Cells® Stem Cell Treatment for Traumatic Spinal Cord Injury | Pharmtech Focus

Dutch Stem Cell Biotech Neuroplast Announces Successful Clinical Phase I Trial with Neuro-Cells® Stem Cell Treatment for Traumatic Spinal Cord Injury

November 9 2021

Dutch clinical phase biotech company Neuroplast and Hospital Nacional de Parapléjicos de Toledo in Spain, today […]